Meeder Asset Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,383
Closed -$43K 1104
2021
Q3
$43K Buy
+2,383
New +$43K ﹤0.01% 1135
2020
Q2
Sell
-791
Closed 2012
2020
Q1
$0 Sell
791
-425
-35% ﹤0.01% 2301
2019
Q4
$2K Sell
1,216
-3,379
-74% -$5.56K ﹤0.01% 1984
2019
Q3
$5K Buy
4,595
+3,947
+609% +$4.3K ﹤0.01% 1743
2019
Q2
$1K Sell
648
-1,015
-61% -$1.57K ﹤0.01% 1925
2019
Q1
$10K Buy
1,663
+483
+41% +$2.9K ﹤0.01% 1232
2018
Q4
$9K Buy
+1,180
New +$9K ﹤0.01% 1268
2017
Q2
Sell
-72
Closed -$2K 1635
2017
Q1
$2K Buy
+72
New +$2K ﹤0.01% 1339